-
Hull Friis posted an update 3 months, 2 weeks ago
There is an urgent need for novel drugs for treating cognitive deficits that are defining features of schizophrenia. The individual d- and l-enantiomers of the tetrahydroprotoberberine (THPB) d,l-govadine have been proposed for the treatment of cognitive deficiencies and positive symptoms of schizophrenia, respectively.
We examined the…[Read more]
-
Hull Friis became a registered member 3 months, 2 weeks ago